RecruitingNot ApplicableNCT06453928

Starting Technology in At Risk Type 1 Diabetes Study

Starting Technology in At Risk Type 1 Diabetes (STAR-T1D) Study

Sponsor

University of California, Los Angeles

Enrollment

40 participants

Start Date

Sep 5, 2024

Study Type

INTERVENTIONAL

Conditions

Diabetes Mellitus, Type 1

Summary

Diabetes technology has revolutionized T1D management, disparities in technology access are evident among racial-ethnic minorities, patients with lower socioeconomic status and those with poorly controlled T1D (A1c\>8.5%). In order to examine whether diabetes technology can reduce diabetes care burdens and enhance outcomes among some of highest need patients, diabetes technology clinical trials must be expanded beyond the very select populations included in studies thus far (ie., mostly White, higher SES). Therefore, the investigators propose to perform a pilot RCT of hybrid closed-loop insulin pump therapy (HCL) in 40 diverse adult patients with poorly controlled T1D (HbA1c \>8.5%) from the largest academic and safety net health systems in the Los Angeles region to determine the feasibility of a RCT in this population and identify facilitators and barriers of effective use of closed loop insulin pump therapy in patients with poorly controlled T1D.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study helps adults with poorly controlled type 1 diabetes — those not yet using an insulin pump — transition to insulin pump therapy or a continuous glucose monitor (CGM). It focuses on people with higher blood sugar levels (A1c above 8.5%) who speak English or Spanish and could benefit from diabetes technology. **You may be eligible if...** - You have type 1 diabetes - Your most recent A1c (a 3-month average blood sugar measure) is above 8.5% - You are not currently using an insulin pump - Your primary language is English or Spanish - You have medical insurance coverage **You may NOT be eligible if...** - You have not had an A1c measured in the past year - You are pregnant - You have a condition that affects the accuracy of A1c testing - You have cognitive or physical limitations that prevent using diabetes technology Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.